Abstract
Final Report on the Pilot Trial to Verify the Effects of Activated Piroctone Olamine (Label 100Ml) in the Management of Psoriasis and Seborrhoeic Dermatitis in Patients Aged 15 to 60 Years
This is a members-only content. Please log in to access it.